Showing results (241-250 of 275) with videos related to

Sort By:
Pageof 28
Journal for Immunotherapy of Cancer|November 12, 2020
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratioErika J Crosby, Amy C Hobeika, Donna Niedzwiecki, et al.
Vaccines|November 26, 2024
Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate CancerRobert D Marek, Selena Halabi, Mu-En Wang, et al.
Breast Cancer Research : BCR|August 11, 2018
Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancersTakuya Osada, Zachary C Hartman, Junping Wei, et al.
Oncoimmunology|May 17, 2017
Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapyJun Ren, William R Gwin, Xinna Zhou, et al.
NPJ Vaccines|March 17, 2026
Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccinesXingru Ma, Robert D Marek, Susannah Gammell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineTakuya Osada, Christopher Y Woo, Matthew McKinney, et al.
Vaccine|October 18, 2011
Increasing vaccine potency through exosome antigen targetingZachary C Hartman, Junping Wei, Oliver K Glass, et al.
Breast Cancer Research and Treatment|July 10, 2016
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasionAbhijit Mazumdar, Graham M Poage, Jonathan Shepherd, et al.
JCI Insight|February 15, 2022
Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosisLi-Chung Tsao, Erika J Crosby, Timothy N Trotter, et al.
Oncoimmunology|May 4, 2018
Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumorsErika J Crosby, Junping Wei, Xiao Yi Yang, et al.
Pageof 28